WAGNER CHARLES F JR (EVP and CFO) sold 6.5% of their position (3.25K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.50M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2024ACC: 0000875320-24-000170
Officer· EVP and CFO
Since Apr 2019
-3.25K
Net shares
Net seller
$1.50M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.25K
Price / share
$460.00
Trade value
$1.50M
% of position
6.5%
6/3/2024
50.39K→47.14K
Total
Net shares
−3.25K
Net value
-$1.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2024 | S · Sale | −3.25K | $460.00 | $1.50M | 6.5% | 50.39K | 47.14K |
| Total | −3.25K | -$1.50M | ||||||
Derivative Transactions0
No derivative transactions reported